Monoclonal Antibodies, Inc.
United StatesFDA applicant, unverified
- Devices
- 14
What Monoclonal Antibodies, Inc. makes
Monoclonal Antibodies, Inc. manufactures diagnostic test kits and assays for detecting human chorionic gonadotropin (HCG), luteinizing hormone (LH), and herpes simplex virus (HSV) in urine samples. These include products such as the UCG Assay, Ovustick Urine HLH Kit, Plus Urine HCG Assay, B-Clone HCG Assay, Ovustick Self-Test, Pregnastick Urine HCG Kit, Ovquick Self-Test (Ovuquick; Ramp LH Assay), Ramp Progesturine PDG Assay--48 Test Kit, Ramp Urine HCG Assay, HCG Control Kit, and Ovustick Self-Test -Modification.
The company's devices are classified as Class I and Class II medical devices and are listed in the FDA 510(k) registry. Monoclonal Antibodies, Inc. is based in the United States.
Catalogue
Search and filter all 14 devicesFrequently asked questions
How many devices does Monoclonal Antibodies, Inc. have in the registry?
The registry currently lists 14 devices for Monoclonal Antibodies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Monoclonal Antibodies, Inc.'s devices?
Among its 14 most recently registered devices, Monoclonal Antibodies, Inc. has devices listed in FDA 510(k) (14 devices).
What risk classes do Monoclonal Antibodies, Inc.'s devices fall under?
Among its 14 most recently registered devices, the classes recorded for Monoclonal Antibodies, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Monoclonal Antibodies, Inc. in the registry?
The most recently registered devices listed for Monoclonal Antibodies, Inc. include MODEL UCG ASSAY, OVU STICK URINE HLH KIT, PLUS URINE HCG ASSAY and B-CLONE HCG ASSAY.